BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2023 2:28:02 PM | Browse: 174 | Download: 512
 |
Received |
|
2023-08-21 09:34 |
|
Peer-Review Started |
|
2023-08-21 09:34 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-09-04 02:57 |
|
Revised |
|
2023-09-12 06:57 |
|
Second Decision |
|
2023-09-21 02:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-22 07:28 |
|
Articles in Press |
|
2023-09-22 07:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-27 06:49 |
|
Publish the Manuscript Online |
|
2023-10-13 14:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Meta analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Pei Wang and Sheng-Yu Jin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sheng-Yu Jin, PhD, Chief Doctor, Doctor, Doctor, Library Staff, Department of Hematology, Yanbian University Hospital, 1327 Juzi Street, Yanji 133000, Jilin Province, China. jinsy11@163.com |
| Key Words |
Multiple myeloma; Daratumumab; Efficacy; Safety; Meta-analysis |
| Core Tip |
Daratumumab demonstrates promising efficacy in treating multiple myeloma, improving the ORR, CR, and PFS, compared to other therapies. However, it is also associated with an increased risk of neutropenia and thrombocytopenia. Clinicians should closely monitor their patients for these adverse effects. Further studies are needed to explore optimal dosing and combination therapies to maximize the benefits of dDaratumumab in treating multiple myeloma. |
| Publish Date |
2023-10-13 14:28 |
| Citation |
Wang P, Jin SY. Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma. World J Clin Cases 2023; 11(29): 7091-7100 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i29/7091htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i29.7091 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
